.decimal, LLC

Based in the US, . decimal, LLC specializes in the design and delivery of custom, patient-specific treatment devices tailored for cancer patients, focusing on enhancing treatment efficacy and patient comfort through personalized medical solutions. Founded in 1986 and headquartered in Sanford, US, . decimal, LLC designs individualized treatment devices for cancer care.

The company has remained focused on this mission without significant pivots in strategy. In May 2026, . decimal was acquired by CQ Medical, a portfolio company of Blue Wolf Capital Partners, although financial terms were not disclosed. The founder's history is not specified in the provided information..

decimal specializes in the on-demand design and delivery of custom, patient-specific treatment devices tailored for cancer patients. Their offerings focus on creating individualized medical devices that enhance treatment efficacy and patient comfort, ensuring alignment with the unique anatomical and therapeutic needs of users. The company's services primarily target healthcare providers, including 949 clinics across the United States, which utilize these devices to improve patient outcomes in cancer care, optimizing radiotherapy and enhancing the overall patient experience. By focusing on personalized treatment, .

decimal responds to the growing demand for precision medicine in the healthcare sector. The revenue model for . decimal is structured around business-to-business transactions with clinics and healthcare facilities that purchase their custom treatment devices. This approach allows for close collaboration to meet specific patient needs, although exact pricing details are not disclosed.

The company engages in agreements reflective of their bespoke products, likely involving volume-based pricing or subscription models for ongoing supply. Revenue generation includes sales of individual devices and additional services such as design consultations and ongoing support, establishing a comprehensive service offering for healthcare clients. With the recent acquisition by CQ Medical in May 2026, the strategy for future growth includes enhancing business development initiatives. The acquisition aims to leverage CQ Medical’s resources to explore new market opportunities and expand operations.

While specific new products or geographic markets targeted for expansion have not been detailed, the integration is expected to facilitate broader outreach within the healthcare sector.